SOPH
What one share of SOPHiA GENETICS SA holds
Services – Computer Processing and Data Preparation
SOPHiA GENETICS was founded to generate clinically actionable insights from data to improve patient outcomes. Our mission is to provide equal access to knowledge and capabilities by democratizing data-driven medicine.
SOPHiA GENETICS SA’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $1.14 |
|---|---|
| Profit | −$1.17 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.54 |
| Cash and investments | $1.03 |
| Debt | $0.70 |
| Book value | $0.69 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $0.67 | −$0.93 | $0.01 | −$0.76 | — | $2.37 |
| 2021 | $0.73 | −$1.33 | $0.05 | −$1.10 | — | $4.31 |
| 2022 | $0.74 | −$1.36 | $0.06 | −$1.16 | — | $3.12 |
| 2023 | $0.96 | −$1.22 | $0.02 | −$0.85 | — | $2.32 |
| 2024 | $0.99 | −$0.95 | $0.00 | −$0.68 | — | $1.45 |
| 2025 | $1.14 | −$1.17 | $0.01 | −$0.54 | — | $0.69 |